top of page

About Us

Cannabis Consumer Watch is a project of National Consumers League

The National Consumers League (NCL) is America’s premier consumer advocacy organization, with a rich history of fighting to make the marketplace fair, safe, and healthy for consumers.  

Since NCL’s founding in 1899, NCL has pursued the values of access to quality products, honest labeling, and safe, effective medicines for America’s consumers. At the 1904 St. Louis World’s Fair, NCL pulled back the curtain on vegetable products dyed by manufacturers to look fresh. NCL was instrumental in the passage of the 1906 Pure Food and Drugs Act, landmark legislation that helped improve truth in labeling, raised industry standards, and established oversight by government agencies, which would ultimately become the Food and Drug Administration (FDA).  

More than a century later, NCL continues this work to ensure a safe food and drug supply for our country. For decades, NCL has worked in partnership with the FDA on the most important issues in food and drug safety and to collaborate on improving consumer education. The FDA has a great track record of keeping America safe, but the marketplace is frequently evolving, and regulation must keep up.  

In 2019, in response to the proliferation of unreviewed and untested CBD products, NCL identified the need for greater education among consumers about CBD and better enforcement of regulations in the CBD marketplace. NCL created Consumers for Safe CBD to address this need, champion the rights of consumers, and call on government and industry to do better – to ensure safety and promote a pathway for new products through clinically tested scientific research.  

Since then, action has been taken on the state and federal levels to increase access to cannabinoids beyond CBD, which is why NCL is now shifting its focus to cannabis more broadly with the establishment of Cannabis Consumer Watch.  


Asset 1_2x.png
Asset 1_2x.png

Cannabis Consumer Watch is working to educate consumers about the potential dangers of cannabis in an unregulated market and to encourage the Food and Drug Administration (FDA) to take strong, effective, and prompt action to protect the public from the potential harms posed by unregulated, untested cannabinoids.

Asset 1_2x.png
bottom of page